US cancer institute suspends trialBMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6934.936a (Published 09 April 1994) Cite this as: BMJ 1994;308:936
- J Roberts
The head of North America's biggest breast cancer study group has stepped aside at the insistence of the US National Cancer Institute. Dr Bernard Fisher, a professor of surgery at the University of Pittsburgh, was asked to resign his leadership of the national surgical adjuvant breast and bowel project, which has run more than 10 major treatment trials for breast cancer. He quickly announced that he would leave his post. In addition to seeking …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial